Physician

Samer S Suki, MD

According to 2025 Medicare claims, Samer Suki, MD (NPI: 1639132962) practices hematology/oncology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is MILLENNIUM PHYSICIANS ASSOCIATION, PLLC (NPI: 1255397733; TIN: 760528826) and primary practice location at 77380-3485. Suki is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Suki's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 622 traditional Medicare patients, billed 346,979 HCPCS/CPT codes, and received $4,606,991 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 2,898 prescription claims across 420 beneficiaries totaling $4,881,823 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 25 claims. Open Payments data shows 131 records totaling $3,351. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,615,128 to $4,606,991. Similarly, Part D prescription costs have risen steadily, from $2,085,289 to $4,881,823. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $646 to $5,244.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	604	376,467	$2,615,128
2016	658	408,498	$2,891,311
2017	600	389,389	$3,018,723
2018	557	366,414	$3,693,267
2019	570	255,536	$3,879,108
2020	537	342,688	$4,291,833
2021	506	226,299	$3,831,416
2022	537	279,782	$3,765,884
2023	514	285,686	$4,391,202
2024	622	346,979	$4,606,991

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	285	1,713	$2,085,289
2016	289	1,688	$2,232,628
2017	332	2,058	$3,402,526
2018	311	1,932	$3,598,657
2019	319	1,991	$3,166,798
2020	298	1,918	$2,872,881
2021	263	1,551	$2,546,246
2022	289	1,618	$3,067,271
2023	317	2,371	$3,687,874
2024	420	2,898	$4,881,823

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	45	$2,647
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	13	$824
2022	N/R	N/R	N/R
2023	N/R	12	$512
2024	N/R	25	$1,499

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78815	Nuclear medicine study from skull base to mid-thigh with ct scan	108	178	$1,163
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	93	93	$116
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	91	149	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	483	1,775	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	113	123	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	38	1,064	$641,653
Tagrisso	Osimertinib Mesylate	32	960	$523,708
Promacta	Eltrombopag Olamine	34	1,180	$446,472
Kisqali	Ribociclib Succinate	20	560	$272,915
Nubeqa	Darolutamide	21	630	$271,620

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4407	Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each	N	N/R	13	$1,077
A4432	Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each	N	N/R	12	$422

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	131	$3,351	US Oncology Corporate, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Samer S. Suki, MD?

Tedicare shows public-source Medicare data for Samer S. Suki, MD (NPI 1639132962), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samer S. Suki, MD have ACO affiliation data?

Samer S. Suki, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Samer S. Suki, MD?

Samer S. Suki, MD is linked to MILLENNIUM PHYSICIANS ASSOCIATION, PLLC (billing NPI 1255397733) in the available physician profile data.

Does Samer S. Suki, MD have Open Payments data?

Samer S. Suki, MD has 131 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.